Skip to main
University-wide Navigation

Projects to Date


Grants Facilitated


Departments Engaged

A Commitment to Positive Impact Throughout the Commonwealth

The Center for Pharmaceutical Research and Innovation (CPRI) facilitates basic and clinical research in drug discovery and development. The CPRI assists UK-based researchers to identify novel chemical probes and drug leads to address unmet medical needs in various disease areas and assisting in advancing projects to in vivo preclinical proof of principle. Through our Computational, Synthesis, and Translational Cores, and our Natural Products Library we provide unique services and build innovative research collaborations with investigators across the university.

Research Cores and Resources

The CPRI provides core services, state-of-the-art facilities, and unique expertise to facilitate translational research.

CPRI Collaborative Projects

CPRI works with many talented UK investigators and the network of world-class UK Centers focused on major health disparities in the Commonwealth.


Our scientists are the intellectual engine of CPRI and innovators in team-driven probe/lead discovery, development, and commercialization.


Prisinzano Named New Director

The CPRI welcomes Dr. Tom Prisinzano as the new director.

Seeking Cures in Kentucky Coal Mines

Read more about how natural products-based lead to discovery in our Newsweek feature.


NIH Awards $11.2 Million for Pharmaceutical Research and Innovation Center at UK

The University of Kentucky was awarded a prestigious Centers of Biomedical Research Excellence (COBRE) grant to study translational chemical biology from the National Institutes of General Medical Sciences, part of the National Institutes of Health.


The CPRI seeks to develop innovative research partnerships with UK investigators. For more information and to request services, please contact us.

Contact Us

Funding Acknowledgment Statement

This work was supported by the Center for Pharmaceutical Research and Innovation (CPRI, NIH P20 GM130456) and the National Center for Advancing Translational Sciences (UL1 TR001998).

We respectfully acknowledge the Elders and Traditional Owners of the land on which our building stands, which is the traditional territory of the Osage, Shawnee, Cherokee, Adena, and Hopewell peoples.